Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Dauben

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Expert Review of Pharmacoeconomics & Outcomes Research|September 2, 2024
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriersMaximillian Otte, Hans Peter Dauben, Jeonghoon Ahn, et al.
International Journal of Technology Assessment in Health Care|June 11, 2002
Health promotion and disease prevention as a complement to community health indicators. Working group 1Hans-Peter Dauben, Olav Helge Førde, Marlène Laeubli Loud, et al.
Frontiers in Pharmacology|August 29, 2025
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilarsMaximilian Otte, Zoltán Kaló, Hussain Abdulrahman Al-Omar, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?Denis Horgan, Tanja Spanic, Kathi Apostolidis, et al.
Surgical Endoscopy|January 8, 2010
EAES recommendations on methodology of innovation management in endoscopic surgeryEdmund A M Neugebauer, Monika Becker, Gerhard F Buess, et al.
Clinical Pharmacology and Therapeutics|March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARLQuynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Frontiers in Public Health|October 24, 2022
A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agenciesNora Ibargoyen-Roteta, Lorea Galnares-Cordero, Gaizka Benguria-Arrate, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Expert Review of Pharmacoeconomics & Outcomes Research|September 2, 2024
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriersMaximillian Otte, Hans Peter Dauben, Jeonghoon Ahn, et al.
International Journal of Technology Assessment in Health Care|June 11, 2002
Health promotion and disease prevention as a complement to community health indicators. Working group 1Hans-Peter Dauben, Olav Helge Førde, Marlène Laeubli Loud, et al.
Frontiers in Pharmacology|August 29, 2025
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilarsMaximilian Otte, Zoltán Kaló, Hussain Abdulrahman Al-Omar, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?Denis Horgan, Tanja Spanic, Kathi Apostolidis, et al.
Surgical Endoscopy|January 8, 2010
EAES recommendations on methodology of innovation management in endoscopic surgeryEdmund A M Neugebauer, Monika Becker, Gerhard F Buess, et al.
Clinical Pharmacology and Therapeutics|March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARLQuynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Frontiers in Public Health|October 24, 2022
A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agenciesNora Ibargoyen-Roteta, Lorea Galnares-Cordero, Gaizka Benguria-Arrate, et al.
Pageof 2